封面
市场调查报告书
商品编码
1797022

生物安全柜市场-全球产业规模、份额、趋势、机会和预测(按类型、最终用户、地区和竞争细分,2020-2030 年)

Biological Safety Cabinet Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type, By End User, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球生物安全柜市场价值为 2.8726 亿美元,预计到 2030 年将达到 4.5587 亿美元,预测期内的复合年增长率为 8.00%。全球生物安全柜市场正在经历显着成长,这得益于传染病风险的上升以及生物技术和製药公司研发活动的增加。生物安全柜也称为生物安全柜。它是一个封闭的通风工作空间,可以安全地处理受病原体污染的元素,这需要指定的生物安全等级。其他支持市场成长的因素包括对治疗慢性病的个人化医疗的需求不断增长,以及患有慢性病的老龄人口不断增长。此外,医疗领域研发活动的增加和各种新技术的采用率上升也是市场成长的因素。

市场概览
预测期 2026-2030
2024年市场规模 2.8726亿美元
2030年市场规模 4.5587亿美元
2025-2030 年复合年增长率 8.00%
成长最快的领域 诊断和检测实验室
最大的市场 北美洲

关键市场驱动因素

提高病原体研究中实验室生物安全意识

主要市场挑战

高昂的初始成本和营运成本

主要市场趋势

智慧、节能的 BSC 设计创新

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球生物安全柜市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依类型(I类、II类、III类)
    • 按最终用户(製药和生物製药公司、诊断和检测实验室、学术和研究组织)
    • 按地区
    • 按公司分类(2024)
  • 市场地图
    • 按类型
    • 按最终用户
    • 按地区

第六章:北美生物安全柜市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲生物安全柜市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太生物安全柜市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美洲生物安全柜市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲生物安全柜市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品/服务的威胁

第 14 章:全球生物安全柜市场:SWOT 分析

第 15 章:竞争格局

  • Thermo Fisher Scientific, Inc.
  • Labconco Corp.
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • Cruma SA
  • Jinan Biobase Biotech Co. Ltd.
  • Azbil Telstar
  • Germfree Laboratories, Inc.
  • Air Science, Inc.

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 14330

Global Biological Safety Cabinet Market was valued at USD 287.26 million in 2024 and is expected to reach USD 455.87 million by 2030 with a CAGR of 8.00% during the forecast period. The global market for Biological Safety Cabinet is experiencing significant growth, driven by the rising risk of communicable diseases and increasing research and development activities in biotechnology and pharmaceutical companies. Biological Safety Cabinets is also known as biosafety cabinets. It is an enclosed ventilated workspace that enables safety working with elements contaminated with pathogens, which requires a designated biosafety level. The other factors supporting the market's growth are the growing demand for personalized medicine for the treatment of chronic diseases, and the growing aging population with chronic diseases. Moreover, the rise in the research and development activities in the medical sector and the rise in the adoption of various new technologies are the contributing factors to the growth of the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 287.26 Million
Market Size 2030USD 455.87 Million
CAGR 2025-20308.00%
Fastest Growing SegmentDiagnostics & Testing Laboratories
Largest MarketNorth America

Key Market Drivers

Escalating Awareness of Lab Biosafety in Pathogen Research

The recent focus on high-risk pathogen handling-especially following outbreaks such as COVID 19, Ebola, and anthrax lapses-has catalyzed a global push towards safer laboratory environments. Biosafety cabinets are central to these efforts, offering primary containment to reduce staff exposure and environmental pollution. In the United States, repeated audits by the CDC and Department of Health have highlighted biosafety lapses, prompting reforms and procedural overhauls. International bodies such as the World Health Organization (WHO) also stress strict biosafety practices. For example, in 2023 WHO supported certification training in Nepal to strengthen national biosafety capacity. As pandemic preparedness becomes a policy priority, national health agencies are investing in BSCs-especially Class II and III-to ensure safe handling of emerging pathogens. Such measures align with recommended biosafety upgrade plans and global health compliance frameworks, boosting BSC market demand.

Key Market Challenges

High Initial and Operational Costs

Despite regulatory backing, cost remains a barrier for many laboratories. Advanced Class II and III units-with HEPA filters, air handling ducting, and smart electronics-can be prohibitively expensive, especially in resource-limited settings. Even after purchase, recurring costs related to HEPA filter replacements, airflow testing equipment, and annual NSF/ANSI certifications add up.

Improper or inadequate installation, lack of trained personnel, and budget constraints can reduce compliance. As noted in Southeast Asian labs, ~30% of BSCs were found to be mis installed or improperly maintained. Without sustained funding, especially in low-income institutions, these safety-critical systems may lapse into disuse or underperformance-posing regulatory and biohazard risks.

Key Market Trends

Innovation in Smart, Energy-Efficient BSC Designs

A major ongoing trend is the rise of smart, energy-efficient biosafety cabinets. Manufacturers are integrating digital airflow monitoring, automated sash control, and IoT-enabled alerts for filter replacement or airflow disruptions. Some advanced models self-adjust airflow when idle, reducing energy usage by up to 30%, along with LED lighting and efficient motors that further cut operating costs.

Cabinets designed to fit in space-constrained microbiology or pharmaceutical labs-often with laminar and containment airflow modes-are gaining popularity. These smart and sustainable innovations align with institutional goals to improve safety while minimizing carbon footprint and operational expense, signaling a shift toward eco-conscious laboratory design.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • Labconco Corp.
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • Cruma S.A.
  • Jinan Biobase Biotech Co. Ltd.
  • Azbil Telstar
  • Germfree Laboratories, Inc.
  • Air Science, Inc.

Report Scope:

In this report, the Global Biological Safety Cabinet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Safety Cabinet Market, By Type:

  • Class I
  • Class II
  • Class III

Biological Safety Cabinet Market, By End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostics & Testing Laboratories
  • Academic & Research Organizations

Biological Safety Cabinet Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biological Safety Cabinet Market.

Available Customizations:

Global Biological Safety Cabinet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Safety Cabinet Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Class I, Class II, Class III)
    • 5.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By End User
    • 5.3.3. By Region

6. North America Biological Safety Cabinet Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Class I, Class II, Class III)
    • 6.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biological Safety Cabinet Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Biological Safety Cabinet Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Biological Safety Cabinet Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Biological Safety Cabinet Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Class I, Class II, Class III)
    • 7.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Biological Safety Cabinet Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Biological Safety Cabinet Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Biological Safety Cabinet Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Biological Safety Cabinet Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Biological Safety Cabinet Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Biological Safety Cabinet Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Class I, Class II, Class III)
    • 8.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biological Safety Cabinet Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Biological Safety Cabinet Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Biological Safety Cabinet Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Biological Safety Cabinet Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Biological Safety Cabinet Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. South America Biological Safety Cabinet Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Class I, Class II, Class III)
    • 9.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biological Safety Cabinet Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Biological Safety Cabinet Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Biological Safety Cabinet Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Biological Safety Cabinet Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Class I, Class II, Class III)
    • 10.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biological Safety Cabinet Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Biological Safety Cabinet Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Biological Safety Cabinet Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Global Biological Safety Cabinet Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Labconco Corp.
  • 15.3. NuAire, Inc.
  • 15.4. The Baker Company, Inc.
  • 15.5. Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • 15.6. Cruma S.A.
  • 15.7. Jinan Biobase Biotech Co. Ltd.
  • 15.8. Azbil Telstar
  • 15.9. Germfree Laboratories, Inc.
  • 15.10. Air Science, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer